Fine chemicals company Rohner is to work together with
Switzerland's Solvias on the provision of development and
manufacturing services for complex active pharmaceutical
ingredients (APIs).
Germany's BASF has entered into a collaboration with Solvias of
Switzerland that will see the two companies combine their expertise
in the development and manufacture of chiral intermediates for the
life science industry.
Codexis has appointed a new head of biocatalysis and chemical
development, shoring up its expertise in what is a small but
fast-growing area of the catalysts market.
German chemistry specialist ChiroBlock has pulled out of the
business of producing and marketing chiral compounds and will focus
exclusively on providing chiral research and synthesis services for
pharmaceutical and biotechnology...